Skip to content

Artificial Intelligence-guided Precision Treatment of High-grade Serous Ovarian Carcinoma

Personalized Precision Diagnosis and Treatment of High-grade Serous Ovarian Carcinoma During the Perioperative Period Assisted by Multi-omics and Artificial Intelligence Models, and Research on the Heterogeneity of Immune Microenvironment

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07721675
Acronym
AI-PTHGSOC
Enrollment
1300
Registered
2026-07-23
Start date
2026-08-01
Completion date
2027-12-31
Last updated
2026-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-grade Serous Ovarian Carcinoma (HGSOC)

Brief summary

The subjects of this study are patients with high-grade serous ovarian cancer who have undergone surgical resection. The aim is to construct an artificial intelligence model for predicting postoperative recurrence, metastasis and overall survival of patients based on multimodal data such as surgical pathological images (HE images and IHC images of immune microenvironment-related markers), preoperative baseline imaging data and detailed clinical information of patients. In addition, multi-omics sequencing analysis will be used to deeply explore the heterogeneity of the tumor microenvironment, with the expectation of quantifying the postoperative recurrence risk of patients with high-grade serous ovarian cancer and providing new ideas for the precise diagnosis and treatment of patients with high-grade serous ovarian cancer.

Interventions

OTHERNo Intervention: Observational Cohort

This study is an retrospective observational study. There will be no interventions on the participants.

Sponsors

The Affiliated Hospital of Qingdao University
Lead SponsorOTHER
Shandong Provincial Hospital
CollaboratorOTHER_GOV
Yantai Yuhuangding Hospital
CollaboratorOTHER
Peking University Third Hospital
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Histologically confirmed high-grade serous ovarian carcinoma using resection specimens. * Well-preserved surgical paraffin-embedded tumor specimens. * Complete clinical information and survival follow-up data.

Exclusion criteria

* Received preoperative neoadjuvant treatment. * Poor preservation of surgical paraffin specimens. * Incomplete clinical information and survival follow-up data. * With concurrent malignancies other than high-grade serous ovarian carcinoma.

Design outcomes

Primary

MeasureTime frame
Disease-free survivalthrough study completion, an average of 1 year

Contacts

CONTACTXiaoming Xing
edithxing@126.com+8653282911869

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 24, 2026